Saksena Asheesh

SEC source: 0000897101-26-000320 · edgardoc.xml · derivative · entry 3

Saksena Asheesh · CIK 0001701497 · Chief S&G Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,832

Underlying: Common Stock · 58,832 shares

Expires 2036-08-06

F1 · derivative.exercise_date: Option vests in four equal annual installments beginning on July 6, 2027.

SEC source: 0000897101-26-000320 · edgardoc.xml · nonDerivative · entry 1

Saksena Asheesh · CIK 0001701497 · Chief S&G Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,009

SEC source: 0000897101-26-000288 · edgardoc.xml · nonDerivative · entry 1

Saksena Asheesh · CIK 0001701497 · Chief S&G officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,946

SEC source: 0000897101-25-000522 · edgardoc.xml · nonDerivative · entry 1

Saksena Asheesh · CIK 0001701497 · Chief S&G Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,474

SEC source: 0000897101-25-000402 · edgardoc.xml · derivative · entry 3

Saksena Asheesh · CIK 0001701497 · Chief S&G Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,016

Underlying: Common Stock · 41,016 shares

Expires 2035-07-30

F1 · derivative.exercise_date: Option vests in four equal annual installments beginning on June 30, 2026.

SEC source: 0000897101-25-000402 · edgardoc.xml · nonDerivative · entry 1

Saksena Asheesh · CIK 0001701497 · Chief S&G Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,860

SEC source: 0000897101-24-000447 · edgardoc.xml · derivative · entry 2

Saksena Asheesh · CIK 0001701497 · Chief S&G Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,277

Underlying: Common Stock · 28,277 shares

Expires 2034-10-09

F1 · shares: Option vests in four equal annual installments beginning on September 09, 2025.

SEC source: 0000897101-24-000447 · edgardoc.xml · nonDerivative · entry 1

Saksena Asheesh · CIK 0001701497 · Chief S&G Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,656

SEC source: 0000039911-23-000003 · edgardoc.xml · derivative · entry 3

Saksena Asheesh · CIK 0001701497 · Chief Growth Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,218

Underlying: Common Stock · 44,663 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Gap Inc. Common Stock.

F2 · derivative.exercise_date: On January 11, 2021, the reporting person was granted 133,988 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.

F2 · derivative.expiration_date: On January 11, 2021, the reporting person was granted 133,988 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0000039911-23-000003 · edgardoc.xml · nonDerivative · entry 2

Saksena Asheesh · CIK 0001701497 · Chief Growth Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,923.3996

SEC source: 0000039911-23-000003 · edgardoc.xml · nonDerivative · entry 1

Saksena Asheesh · CIK 0001701497 · Chief Growth Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,954.3996

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001701497-22-000003 · edgardoc.xml · derivative · entry 5

Saksena Asheesh · CIK 0001701497 · Chief Growth Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 147,881

Underlying: Common Stock · 5,763 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Gap Inc. Common Stock.

F5 · derivative.exercise_date: On March 15, 2021, the reporting person was granted 23,053 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.

F5 · derivative.expiration_date: On March 15, 2021, the reporting person was granted 23,053 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001701497-22-000003 · edgardoc.xml · nonDerivative · entry 2

Saksena Asheesh · CIK 0001701497 · Chief Growth Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,291.3996

SEC source: 0001701497-22-000003 · edgardoc.xml · nonDerivative · entry 1

Saksena Asheesh · CIK 0001701497 · Chief Growth Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,148.3996

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Balance adjusted to reflect shares acquired under the Gap Inc. Employee Stock Purchase Plan.

SEC source: 0001701497-22-000003 · edgardoc.xml · derivative · entry 4

Saksena Asheesh · CIK 0001701497 · Chief Growth Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 153,644

Underlying: Common Stock · 41,265 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Gap Inc. Common Stock.

F4 · derivative.exercise_date: On March 14, 2022, the reporting person was granted 41,265 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.

F4 · derivative.expiration_date: On March 14, 2022, the reporting person was granted 41,265 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001701497-22-000003 · edgardoc.xml · derivative · entry 3

Saksena Asheesh · CIK 0001701497 · Chief Growth Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,453

Underlying: Common Stock · 117,453 shares

Expires 2032-03-14

F2 · derivative.exercise_date: On March 14, 2022, the reporting person was granted an option to purchase a total of 117,453 shares, vesting in four equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001701497-22-000002 · edgardoc.xml · derivative · entry 3

Saksena Asheesh · CIK 0001701497 · Chief Growth Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112,379

Underlying: Common Stock · 44,662 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Gap Inc. Common Stock.

F3 · derivative.exercise_date: On January 11, 2021, the reporting person was granted 133,988 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.

F4 · derivative.expiration_date: Not applicable.

SEC source: 0001701497-22-000002 · edgardoc.xml · nonDerivative · entry 2

Saksena Asheesh · CIK 0001701497 · Chief Growth Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,820.9441

SEC source: 0001701497-22-000002 · edgardoc.xml · nonDerivative · entry 1

Saksena Asheesh · CIK 0001701497 · Chief Growth Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,638.9441

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Balance adjusted to reflect shares acquired under the Gap Inc. Employee Stock Purchase Plan.

SEC source: 0000039911-21-000035 · edgardoc.xml · derivative · entry 2

Saksena Asheesh · CIK 0001701497 · Chief Growth Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 157,041

Underlying: Common Stock · 23,053 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Gap Inc. Common Stock.

F3 · derivative.exercise_date: On March 15, 2021, the reporting person was granted 23,053 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.

F3 · derivative.expiration_date: On March 15, 2021, the reporting person was granted 23,053 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0000039911-21-000035 · edgardoc.xml · derivative · entry 1

Saksena Asheesh · CIK 0001701497 · Chief Growth Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,875

Underlying: Common Stock · 67,875 shares

Expires 2031-03-15

F1 · derivative.exercise_date: On March 15, 2021, the reporting person was granted an option to purchase a total of 67,875 shares, vesting in four equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0000039911-21-000006 · edgardoc.xml · derivative · entry 2

Saksena Asheesh · CIK 0001701497 · Chief Growth Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 133,988

Underlying: Common Stock · 133,988 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Gap Inc. Common Stock.

F3 · derivative.exercise_date: On January 11, 2021, the reporting person was granted 133,988 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.

F3 · derivative.expiration_date: On January 11, 2021, the reporting person was granted 133,988 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0000039911-21-000006 · edgardoc.xml · derivative · entry 1

Saksena Asheesh · CIK 0001701497 · Chief Growth Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 134,557

Underlying: Common Stock · 134,557 shares

Expires 2031-01-11

F1 · derivative.exercise_date: On January 11, 2021, the reporting person was granted an option to purchase a total of 134,557 shares, vesting in four equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001225208-20-008325 · doc4.xml · nonDerivative · entry 1

Saksena Asheesh · CIK 0001701497 · President, Best Buy Health

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 122,920.583

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.83 to $80.849, inclusive. The reporting person undertakes to provide to BBY, any security holder of BBY, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001225208-20-008226 · doc4.xml · nonDerivative · entry 1

Saksena Asheesh · CIK 0001701497 · President, Best Buy Health

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 134,920.583

F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations upon the vesting of restricted shares and does not represent a discretionary transaction by the reporting person.

SEC source: 0001225208-20-008175 · doc4.xml · nonDerivative · entry 4

Saksena Asheesh · CIK 0001701497 · President, Best Buy Health

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 156,896.583

F4 · shares: Represents the vesting and share settlement of a performance share award approved by the Issuer on April 28, 2017. Performance for this award was measured based on the Issuer's total shareholder return (TSR) compared to the TSR of the companies within the S&P 500 Index, over the 36-month period commencing on January 29, 2017, and ending on February 1, 2020. The performance results and number of shares earned based on the results were approved by the Compensation and Human Resources Committee of the Board of Directors on May 20, 2020.

SEC source: 0001225208-20-008175 · doc4.xml · nonDerivative · entry 3

Saksena Asheesh · CIK 0001701497 · President, Best Buy Health

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 147,104.583

F3 · shares: Represents the vesting and share settlement of a performance share award approved by the Issuer on April 28, 2017. Performance for this award was measured based on the compound growth rate of Issuer's enterprise revenue over the 36-month period commencing on January 29, 2017, and ending on February 1, 2020. The performance results and number of shares earned based on the results were approved by the Compensation and Human Resources Committee of the Board of Directors on May 20, 2020.

SEC source: 0001225208-20-008175 · doc4.xml · nonDerivative · entry 2

Saksena Asheesh · CIK 0001701497 · President, Best Buy Health

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 137,204.583

F2 · shares: Represents the vesting and share settlement of a performance share award approved by the Issuer on March 13, 2017. Performance for this award was measured based on the Issuer's total shareholder return (TSR) compared to the TSR of the companies within the S&P 500 Index, over the 36-month period commencing on January 29, 2017, and ending on February 1, 2020. The performance results and number of shares earned based on the results were approved by the Compensation and Human Resources Committee of the Board of Directors on May 20, 2020.

SEC source: 0001225208-20-008175 · doc4.xml · nonDerivative · entry 1

Saksena Asheesh · CIK 0001701497 · President, Best Buy Health

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,892.583

F1 · shares: Represents the vesting and share settlement of a performance share award approved by the Issuer on March 13, 2017. Performance for this award was measured based on the compound growth rate of Issuer's enterprise revenue over the 36-month period commencing on January 29, 2017, and ending on February 1, 2020. The performance results and number of shares earned based on the results were approved by the Compensation and Human Resources Committee of the Board of Directors on May 20, 2020.

SEC source: 0001225208-20-006578 · doc4.xml · nonDerivative · entry 1

Saksena Asheesh · CIK 0001701497 · President, Best Buy Health

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,456.583

F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations upon the settlement of restricted shares earned as dividend equivalents and does not represent a discretionary transaction by the reporting person.

F2 · balance_after: This number reflects shares acquired under the Best Buy employee stock purchase plan and a periodic acquisition of shares under a dividend reinvestment plan exempt from reporting under Section 16b-3(c).

SEC source: 0001225208-20-005570 · doc4.xml · nonDerivative · entry 1

Saksena Asheesh · CIK 0001701497 · President, Best Buy Health

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,985.834

F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations upon the vesting of restricted shares and does not represent a discretionary transaction by the reporting person.

SEC source: 0001225208-20-005570 · doc4.xml · derivative · entry 2

Saksena Asheesh · CIK 0001701497 · President, Best Buy Health

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,573

Underlying: Common Stock · 12,573 shares

Expires 2030-03-19

F2 · derivative.exercise_date: The date indicated is the grant date and the options vest in three equal annual installments beginning one year from such date.

SEC source: 0001225208-20-005307 · doc4.xml · nonDerivative · entry 2

Saksena Asheesh · CIK 0001701497 · President, Best Buy Health

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 115,508.834

F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations upon the vesting of restricted shares and does not represent a discretionary transaction by the reporting person.

SEC source: 0001225208-20-005307 · doc4.xml · nonDerivative · entry 1

Saksena Asheesh · CIK 0001701497 · President, Best Buy Health

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 118,231.834

F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations upon the vesting of restricted shares and does not represent a discretionary transaction by the reporting person.

SEC source: 0001225208-20-004839 · doc4.xml · nonDerivative · entry 1

Saksena Asheesh · CIK 0001701497 · President, Best Buy Health

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,697.834

F1 · shares: Represents restricted shares earned pursuant to an award approved by the Issuer on March 20, 2019, which was subject to achievement of positive adjusted net earnings as of the end of any fiscal year during the term of the award (the 'Performance Condition'). Satisfaction of the Performance Condition was approved by the Compensation and Human Resources Committee of the Board of Directors on March 9, 2020. The restricted shares will vest in three equal annual installments beginning March 20, 2020.

F2 · balance_after: This number reflects a periodic acquisition of shares under a dividend reinvestment plan exempt from reporting under Section 16b-3(c).

SEC source: 0001225208-19-005208 · doc4.xml · nonDerivative · entry 2

Saksena Asheesh · CIK 0001701497 · President, Best Buy Health

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 234,491.58

F2 · shares: Represents restricted shares earned pursuant to an award approved by the Issuer on March 12, 2018, which was subject to achievement of positive adjusted net earnings as of the end of any fiscal year during the term of the award (the 'Performance Condition'). Satisfaction of the Performance Condition was approved by the Compensation and Human Resources Committee of the Board of Directors on March 11, 2019. The restricted shares will vest in three equal annual installments beginning March 12, 2019.

SEC source: 0001225208-19-005208 · doc4.xml · nonDerivative · entry 1

Saksena Asheesh · CIK 0001701497 · President, Best Buy Health

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 225,575.58

F1 · shares: Represents the vesting and share settlement of performance share awards approved by the Issuer on June 13, 2016. Performance for this award was measured based on the Issuer's total shareholder return (TSR) compared to the TSR of the companies within the S&P 500 Index. The performance results and number of shares earned based on the results were approved by the Compensation and Human Resources Committee of the Board of Directors on March 11, 2019.

SEC source: 0001225208-18-013204 · doc4.xml · nonDerivative · entry 2

Saksena Asheesh · CIK 0001701497 · Chief Strategic Growth Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,168.58

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.60 to $80.593, inclusive. The reporting person undertakes to provide to BBY, any security holder of BBY, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001225208-18-013204 · doc4.xml · nonDerivative · entry 1

Saksena Asheesh · CIK 0001701497 · Chief Strategic Growth Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,077.58

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.60 to $80.645, inclusive. The reporting person undertakes to provide to BBY, any security holder of BBY, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001225208-18-010713 · doc4.xml · nonDerivative · entry 1

Saksena Asheesh · CIK 0001701497 · Chief Strategic Growth Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,477.58

F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations upon the vesting of restricted shares and does not represent a discretionary transaction by the reporting person.

SEC source: 0001225208-18-006244 · doc4.xml · nonDerivative · entry 1

Saksena Asheesh · CIK 0001701497 · Chief Strategic Growth Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,700.936

F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations upon the vesting of restricted shares and does not represent a discretionary transaction by the reporting person.

SEC source: 0001225208-18-005292 · doc4.xml · nonDerivative · entry 1

Saksena Asheesh · CIK 0001701497 · Chief Strategic Growth Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,233.936

F1 · shares: Represents restricted shares earned pursuant to an award approved by the Issuer on March 13, 2017, which was subject to achievement of positive adjusted net earnings as of the end of any fiscal year during the term of the award (the 'Performance Condition'). Satisfaction of the Performance Condition was approved by the Compensation and Human Resources Committee of the Board of Directors on March 2, 2018. The restricted shares will vest in three equal annual installments beginning March 13, 2018.

SEC source: 0001225208-17-011509 · doc4.xml · nonDerivative · entry 1

Saksena Asheesh · CIK 0001701497 · Chief Strategic Growth Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,439.936

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.60 to $56.715, inclusive. The reporting person undertakes to provide to BBY, any security holder of BBY, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001225208-17-011353 · doc4.xml · nonDerivative · entry 1

Saksena Asheesh · CIK 0001701497 · Chief Strategic Growth Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,694.936

F1 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations upon the vesting of restricted shares and does not represent a discretionary transaction by the reporting person.

F2 · balance_after: This number reflects a periodic acquisition of shares under the Best Buy employee stock purchase plan, exempt from reporting under Section 16b-3(c).